SEP 15, 2021 9:00 AM PDT

The Market Leading MALDI Biotyper ® CA System: Past, Present and Future

Sponsored by: Bruker
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract
Date:  September 15, 2021
Time: 9:00am (PDT),  12:00pm (EDT)
 
Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on the innovation and evolution of the FDA-cleared MALDI Biotyper® CA System. The discussion will begin by presenting the evolution of the MALDI-TOF mass spectrometer and the key innovative changes since FDA-clearance in 2013. Dr. Kostrzewa will then discuss the latest expansion of the MALDI Biotyper CA System Reference Library followed by details in the development of the FDA-cleared MBT Sepsityper® Kit US IVD which provides a microbial ID direct from positive blood culture in less than 20 minutes for over 488 organisms. To conclude the presentation, Dr. Kostrzewa will briefly present Bruker's ongoing innovation projects and studies to further enhance technologies to address today’s critical diseases.
 
Learning Objectives
  • Explain the advantages of MALDI-TOF technology over traditional microbiology techniques for microbial identification
  • Discuss how rapid microbial ID testing direct from positive blood cultures can impact patient outcomes
  • Discuss how the implementation of rapid microbial ID testing direct from positive blood cultures can positively impact the clinical institution

 

Only for sale in the USA and Puerto Rico.
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
Loading Comments...
Show Resources